Denali Therapeutics Inc. (DNLI) › EPS (Diluted)Denali Therapeutics Inc. (DNLI) — EPS (Diluted)Annual figures by period end, from SEC filings.2018-12-31: $-0.392019-12-31: $-2.072020-12-31: $0.632021-12-31: $-2.392022-12-31: $-2.602023-12-31: $-1.062024-12-31: $-2.572025-12-31: $-2.97$-2.972018-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-2.97—2026-02-26From 2025-01-012024-12-31$-2.57—2026-02-26From 2024-01-012023-12-31$-1.06—2026-02-26From 2023-01-012022-12-31$-2.60—2025-02-27From 2022-01-012021-12-31$-2.39-479.4%2024-02-28From 2021-01-012020-12-31$0.63—2023-02-27From 2020-01-012019-12-31$-2.07—2022-02-28From 2019-01-012018-12-31$-0.39—2021-02-26From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)